1Warkentin TE, GreinseherA.Heprin-indueedthrombocytope-nia: recognition, treatment and prevention, the Seventh ACCP conference on antithrombotic and thrombolytic therapy [J]. Chest,2004,126(3 suppl): 311s-337s.
4Untch B, Ahmad S, Jeske WP, et al. Prevalence, isotype, and functionality of antiheparin- platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG [J]. Thromb Res, 2002, 105 (2):117-123.
5Poncz M. Mechanistic basis of heparin-induced thrombocytopenia [J]. Semin Thorac Cardiovasc Surg, 2005,17(1): 73-79.
6Gordon H.Guyatt,MD,FCCP, E|ie A.AId,MD,PhD,MPH, Mark Crowther,MD,et al. Antithrombotic Therapy And Prevention Of Thrombosis,gthed:ACCPGuidenlines[J].CHEST, 2012,141 (2)(suppl):7S-47S.
二级参考文献10
1Untch B, Ahmad S, Jeske WP, et al. Prevalence, isotype,and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role oflgG[J]. Thromb Res,
2Blank M, Shoenfeld Y, Tavor S, et al. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells[J]. Int Immunol, 2002, 14(2):121.
6Walenga JM, Jeske WP, Wood J J, et al. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study [J]. Semin Hematol, 1999, 36(1 Suppl 1):22.
7Ng T, Tillyer ML. Warfarin-induced skin necrosis associated with Factor V Leiden and protein S deficiency[J].Clin Lab Haematol, 2001,23(4):261.
8Dager WE, White RH. Treatment of heparin-induced thrombocytopenia[J]. Ann Pharmacother, 2002, 36(3):489.
9Bush RL, Lin PH, Lumsden AB. Image of the month.Heparin-induced thrombocytopenia: stop all heparin therapy and treat with lepirudin[J]. Arch Surg, 2002, 137(2):221.
10Moledina M, Chakir M, Gandhi PJ. A synopsis of the clinical uses of argatroban[J]. J Thromb Thrombolysis,2001, 12(2):141.
